Silk Road Medical Inc
Change company Symbol lookup
Select an option...
SILK Silk Road Medical Inc
FTDR Frontdoor Inc
HD Home Depot Inc
SRCE 1st Source Corp
PNC PNC Financial Services Group Inc
AAPL Apple Inc
MSFT Microsoft Corp
FAZE FaZe Holdings Inc
SSP E W Scripps Co
NHWK NightHawk Biosciences Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Silk Road Medical, Inc. is a medical device company, which is focused on reducing the risk of stroke and its devastating impact. The Company has discovered an approach for the treatment of carotid artery disease called transcarotid artery revascularization, (TCAR), which relies on two concepts: minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain and combines the endovascular techniques with fundamental surgical principles. Its product portfolio includes ENROUTE Transcarotid Neuroprotection System (NPS), ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014 Guidewire, and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. Its ENROUTE Transcarotid Stent System is placed during a period of temporary high-rate blood flow reversal, which is enabled by its ENROUTE Transcarotid NPS. It markets and sells products in the United States through a direct sales organization.

Price
Delayed
$15.07
Day's Change
0.08 (0.53%)
Bid
--
Ask
--
B/A Size
--
Day's High
15.29
Day's Low
14.71
Volume
(Light)

Today's volume of 260,355 shares is on pace to be much lighter than SILK's 10-day average volume of 505,600 shares.

260,355
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.

The EDGAR data presented on this website is sourced from the U.S. Securities and Exchange Commission (SEC), as available on https://www.sec.gov/edgar.shtml.